After grabbing 1.45 million shares, the institutional investor is now in possession of 1.45 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.08% having worth around $0.75 million. Moreover, Sabby Management LLC increased its share by 1.25 million to have a control over 1.25 million shares. And Renaissance Technologies LLC raised its holdings to 12490.0 shares by acquiring 0.22 million shares or 0.94% of the stake.
Tonix Pharmaceuticals Holding Corp (TNXP) concluded trading on December 20, 2023 at a closing price of $0.38, with 13.4 million shares of worth about $5.09 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -77.14% during that period and On Wednesday the price saw a loss of about -36.78%. Currently the company’s common shares owned by public are about 23.85M shares, out of which, 23.83M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 0 times over the past 12 months. They bought 0 shares in 0 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Vanguard Total Stock Market ETF, Vanguard Extended Market Index Fu, and Fidelity Extended Market Index Fu are the top 3 mutual funds which are holding stakes in Tonix Pharmaceuticals Holding Corp Vanguard Total Stock Market ETF is currently holding 0.3 million shares of worth totaling $0.15 million. The company recently came buying 0.0 shares which brought its stake up to 1.25% of the company’s outstanding shares. Vanguard Extended Market Index Fu bought 4500.0 shares, after which its hold over company’s outstanding shares expand to 0.44%, leaving 0.11 million shares with the mutual fund that have a worth of about $54568.0. Fidelity Extended Market Index Fu, after selling 71136.0 shares, have now control over 0.30% of the stake in the company. It holds 19686.0 shares of worth $36848.0.
However, the stock later moved at a day high price of 0.6800, or with a loss of -36.78%. Stock saw a price change of -8.69% in past 5 days and over the past one month there was a price change of -21.12%. Year-to-date (YTD), TNXP shares are showing a performance of -84.43% which decreased to -79.14% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.37 but also hit the highest price of $9.81 during that period. The average intraday trading volume for Tonix Pharmaceuticals Holding Corp shares is 685.12K. The stock is currently trading -22.24% below its 20-day simple moving average (SMA20), while that difference is down -25.70% for SMA50 and it goes to -76.28% lower than SMA200.
Armistice Capital LLC acquired 1.45 million shares of Tonix Pharmaceuticals Holding Corp having value of about $0.75 million. Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) currently have 23.85M outstanding shares and institutions hold larger chunk of about 15.63% of that. Holding of mutual funds in the company is about 13.37% while other institutional holders and individual stake holders have control over 2.27% and — of the stake respectively.
The stock has a current market capitalization of $9.05M and its 3Y-monthly beta is at 2.25. It has posted earnings per share of -$11.23 in the same period. It has Quick Ratio of 1.02 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TNXP, volatility over the week remained 33.48% while standing at 16.21% over the month.
Analysts are in expectations that Tonix Pharmaceuticals Holding Corp (TNXP) stock would likely to be making an EPS of -$1.33 in the current quarter, while forecast for next quarter EPS is -$1.1 and it is -$3.59 for next year. For the current quarter EPS, analysts have given the company a lowest target -$1.64 which is -$0.9 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$3.5 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 61.47% while it is estimated to increase by 68.63% in next year.
